Literature DB >> 9372915

Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway.

H D Wang1, A Trivedi, D L Johnson.   

Abstract

Our previous studies have shown that the hepatitis B virus protein, X, activates all three classes of RNA polymerase III (pol III)-dependent promoters by increasing the cellular level of TATA-binding protein (TBP) (H.-D. Wang et al., Mol. Cell. Biol. 15:6720-6728, 1995), a limiting transcription component (A. Trivedi et al., Mol. Cell. Biol. 16:6909-6916, 1996). We have investigated whether these X-mediated events are dependent on the activation of the Ras/Raf-1 signaling pathway. Transient expression of a dominant-negative mutant Ras gene (Ras-ala15) in a Drosophila S-2 stable cell line expressing X (X-S2), or incubation of the cells with a Ras farnesylation inhibitor, specifically blocked both the X-dependent activation of a cotransfected tRNA gene and the increase in cellular TBP levels. Transient expression of a constitutively activated form of Ras (Ras-val12) in control S2 cells produced both an increase in tRNA gene transcription and an increase in cellular TBP levels. These events are not cell type specific since X-mediated gene induction was also shown to be dependent on Ras activation in a stable rat 1A cell line expressing X. Furthermore, increases in RNA pol III-dependent gene activity and TBP levels could be restored in X-S2 cells expressing Ras-ala15 by coexpressing a constitutively activated form of Raf-1. These events are serum dependent, and when the cells are serum deprived, the X-mediated effects are augmented. Together, these results demonstrate that the X-mediated induction of RNA pol III-dependent genes and increase in TBP are both dependent on the activation of the Ras/Raf-1 signaling cascade. In addition, these studies define two new and important consequences mediated by the activation of the Ras signal transduction pathway: an increase in the central transcription factor, TBP, and the induction of RNA pol III-dependent gene activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372915      PMCID: PMC232540          DOI: 10.1128/MCB.17.12.6838

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  67 in total

1.  An RNA polymerase III-defective mutation in TATA-binding protein disrupts its interaction with a transcription factor IIIB subunit in drosophila cells.

Authors:  A Vilalta; A Trivedi; Z Wang; R G Roeder; D L Johnson
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

2.  Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases.

Authors:  J C Cross; P Wen; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

3.  Proteasome complex as a potential cellular target of hepatitis B virus X protein.

Authors:  J Huang; J Kwong; E C Sun; T J Liang
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5.

Authors:  Y Lin; T Nomura; J Cheong; D Dorjsuren; K Iida; S Murakami
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

5.  Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors.

Authors:  E Seto; P J Mitchell; T S Yen
Journal:  Nature       Date:  1990-03-01       Impact factor: 49.962

6.  The CAAX peptidomimetic compound B581 specifically blocks farnesylated, but not geranylgeranylated or myristylated, oncogenic ras signaling and transformation.

Authors:  A D Cox; A M Garcia; J K Westwick; J J Kowalczyk; M D Lewis; D A Brenner; C J Der
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

7.  Mitotic repression of RNA polymerase III transcription in vitro mediated by phosphorylation of a TFIIIB component.

Authors:  J M Gottesfeld; V J Wolf; T Dang; D J Forbes; P Hartl
Journal:  Science       Date:  1994-01-07       Impact factor: 47.728

8.  The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks.

Authors:  H S Chen; S Kaneko; R Girones; R W Anderson; W E Hornbuckle; B C Tennant; P J Cote; J L Gerin; R H Purcell; R H Miller
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  Hepatitis B virus X protein interacts with a probable cellular DNA repair protein.

Authors:  T H Lee; S J Elledge; J S Butel
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Dominant yeast and mammalian RAS mutants that interfere with the CDC25-dependent activation of wild-type RAS in Saccharomyces cerevisiae.

Authors:  S Powers; K O'Neill; M Wigler
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

View more
  37 in total

1.  Microinjection technique used to study functional interaction between p53 and hepatitis B virus X gene in apoptosis.

Authors:  X W Wang
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

Review 2.  RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.

Authors:  T R Brown; P H Scott; T Stein; A G Winter; R J White
Journal:  Gene Expr       Date:  2000

3.  The mitogen-activated protein (MAP) kinase ERK induces tRNA synthesis by phosphorylating TFIIIB.

Authors:  Zoe A Felton-Edkins; Jennifer A Fairley; Emma L Graham; Imogen M Johnston; Robert J White; Pamela H Scott
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

Review 4.  The enigmatic X gene of hepatitis B virus.

Authors:  Michael J Bouchard; Robert J Schneider
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Abnormal expression of TFIIIB subunits and RNA Pol III genes is associated with hepatocellular carcinoma.

Authors:  Junxia Lei; Songlin Chen; Shuping Zhong
Journal:  Liver Res       Date:  2017-09-09

6.  TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.

Authors:  Shuping Zhong; Jody Fromm; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

7.  Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation.

Authors:  Sandra A S Johnson; Louis Dubeau; Deborah L Johnson
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

8.  Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.

Authors:  Thomas J Owen; John D O'Neil; Christopher W Dawson; Chunfang Hu; Xiaoyi Chen; Yunhong Yao; Victoria H J Wood; Louise E Mitchell; Robert J White; Lawrence S Young; John R Arrand
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

9.  The JNKs differentially regulate RNA polymerase III transcription by coordinately modulating the expression of all TFIIIB subunits.

Authors:  Shuping Zhong; Deborah L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-20       Impact factor: 11.205

Review 10.  Hepatitis B Virus X and Regulation of Viral Gene Expression.

Authors:  Betty L Slagle; Michael J Bouchard
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-08       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.